![Richard Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Peterson
Direktor/Vorstandsmitglied bei
UNIVERSAL INSURANCE HOLDINGS, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Richard D.
Peterson is currently an Independent Director at Universal Insurance Holdings, Inc. since 2014, a Member of The Financial Executives Institute, and Chief Financial Officer at Turn Biotechnologies, Inc. since 2022.
Formerly, Mr. Peterson was Director at The Arizona Center For Nature Conservation; Chief Financial Officer, Treasurer & Executive Vice President at Medicis Pharmaceutical Corp.
from 2011 to 2012; Senior Financial Auditor at PricewaterhouseCoopers LLP from 1992 to 1995; Chief Financial Officer at Clarus Therapeutics, Inc.; CFO & Principal Accounting Officer at NVN Liquidation, Inc. from 2015 to 2017; Chief Financial Officer at Botanix Pharmaceuticals Ltd. from 2019 to 2020; Chief Financial & Accounting Officer at Sienna Biopharmaceuticals, Inc. from 2017 to 2018; Chief Financial Officer at Dermavant Sciences, Inc. from 2018 to 2019; and Chief Financial Officer at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Education includes an undergraduate degree from Arizona State University conferred in 1992.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 28 869 ( 0,1 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Richard Peterson
| Unternehmen | Position | Beginn |
|---|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Direktor/Vorstandsmitglied | 05.06.2014 |
The Financial Executives Institute | Corporate Officer/Principal | 26.05.2009 |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Finanzdirektor/CFO | 01.09.2022 |
Ehemalige bekannte Positionen von Richard Peterson
| Unternehmen | Position | Ende |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Finanzdirektor/CFO | 31.08.2022 |
| BOTANIX PHARMACEUTICALS LIMITED | Finanzdirektor/CFO | 01.05.2020 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Finanzdirektor/CFO | 01.02.2019 |
| SIENNA BIOPHARMACEUTICALS, INC. | Finanzdirektor/CFO | 29.03.2018 |
| NVN LIQUIDATION, INC. | Finanzdirektor/CFO | 23.03.2017 |
Ausbildung von Richard Peterson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Universal Insurance Holdings, Inc.
 Universal Insurance Holdings, Inc. Property/Casualty InsuranceFinance Operates as a holding company whose subsidiaries provides property and casualty insurance services | Finance |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Financial Executives Institute | |
The Arizona Center For Nature Conservation
 The Arizona Center For Nature Conservation Other Consumer ServicesConsumer Services Operates as a zoo that provides conservatory of animals and habitats | Consumer Services |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Clarus Therapeutics Holdings, Inc.
 Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
